Intermittent vs. continuous 1-year cyclosporin use in chronic plaque psoriasis

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 9, 2007, Pages 1203-1208

  Chaidemenos, Giorgos C ^a   Mourellou, O ^a   Avgoustinaki, N ^a   Papakonstantinou, M ^b   Karakatsanis, G ^a   Katsambas, A ^c  

^a Hospital for Skin and Venereal Diseases   (Greece)

^b Department of Anesthesiology   (Greece)

^c A Syngros Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSAGE SCHEDULE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG RESPONSE; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; GENERAL CONDITION IMPROVEMENT; GINGIVA HYPERPLASIA; HUMAN; HYPERTENSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; PSORIASIS; PSORIASIS SEVERITY INDEX; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PSORIASIS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 34548735272     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02226.x     Document Type: Article

References (17)

1. Prens EP, van Joost T, Hegmans JP et al. Effects of cyclosporine on cytokines and cytokine receptors in psoriasis. J Am Acad Dermatol 1995; 33: 947-953.
2. Ho VC. The use of cyclosporine in psoriasis: A clinical review. Br J Dermatol 2004; 150 (Suppl. 67): 1-10.
3. Ho VC, Griffiths CEM, Berth-Jones J et al. Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: A 2-year cohort study. J Am Acad Dermatol 2001; 44: 643-651.
4. Mrovietz U, Faerber I, Henneicke-von Zepelin HH et al. Long-term maintenance therapy with cyclosporine and post-treatment survey in severe psoriasis. Results of a multicenter study. J Am Acad Dermatol 1995; 33: 470-475.
5. Fredrikson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244.
6. Griffiths CEM, Dubertret L, Ellis CN et al. Ciclosporin in psoriasis clinical practice: An international consensus statement. Br J Dermatol 2004; 150 (Suppl. 67): 11-23.
7. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
8. Powles AV, Baker BS, Valdimarsson H et al. Four years of experience with cyclosporine A for psoriasis. Br J Dermatol 1990; 122 (Suppl. 36): 13-19.
9. Vanaclocha F, Puig L, Dauden E et al. Effectiveness of cyclosporine in patients with psoriasis. 9th International Psoriasis Symposium, New York, 17-22 June 2003,
10. Ho VC, Griffiths CEM, Albrecht G et al. Intermittent short courses of cyclosporin (Neoral) for psoriasis unresponsive to topical therapy: A 1-year multicentre, randomized study. Br J Dermatol 1999; 141: 283-291.
11. Touw CR, Hakkaart-Van Roijen L, Verboom P et al. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporine. Br J Dermatol 2001; 144: 967-972.
12. Berth-Jones J, Henderson CA, Munro CS et al. Treatment of psoriasis with intermittent short-course cyclosporine (Neoral). A multicentre study. Br J Dermatol 1997; 136: 527-530.
13. Salek MS, Finlay AY, Lewis JJC, Summer MI. Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporine (Neoral). Quality Life Res 2004; 13: 91-95.
14. Puig L, Vanaclocha F, Dauden E et al. Quality of life in psoriatic patients treated with cyclosporine. 9th International Psoriasis Symposium, New York, 17-22 June 2003.
15. Finlay AY. Current severe psoriasis and the Rule of Tens. Br J Dermatol 2005; 152: 861-867.
16. Kumar B, Sandby K, Kaur I. Cyclosporine in severe psoriasis: An Indian experience. Int J Dermatol 2004; 43: 623-624.
17. Ellis CN, Fradin MS, Hamilton TA, Voorhees JJ. Duration of remission during maintenance cyclosporin therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy. Arch Dermatol 1995; 131: 791-795.